DOI=10.1007/BF00199208
Bruggen J., Sorg C., Macher E.
Membrane associated antigens of human malignant melanoma V: Serological typing of cell lines using antisera from nonhuman primates.
Cancer Immunol. Immunother. 5:53-62(1978)

DOI=10.1007/BF00205883
Bruggen J., Macher E., Sorg C.
Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma.
Cancer Immunol. Immunother. 10:121-127(1981)

PubMed=3485457; DOI=10.1182/blood.V67.4.1139.1139
van Leeuwen A., Schrier P.I., Giphart M.J., Noordermeer I.A., Ruiter D.J., Rubinstein P., van Rood J.J.
TCA: a polymorphic genetic marker in leukemias and melanoma cell lines.
Blood 67:1139-1142(1986)

PubMed=1918136; DOI=10.1083/jcb.115.1.191; PMCID=PMC2289921
Quax P.H.A., van Muijen G.N.P., Weening-Verhoeff E.J.D., Lund L.R., Dano K., Ruiter D.J., Verheijen J.H.
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
J. Cell Biol. 115:191-199(1991)

PubMed=2060184; DOI=10.1007/BF01753729
van Muijen G.N.P., Cornelissen I.L.M.H.A., Jansen K.F.J., Figdor C.G., Johnson J.P., Brocker E.-B., Ruiter D.J.
Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
Clin. Exp. Metastasis 9:259-272(1991)